Livforsakringsbolaget Skandia Omsesidigt Invests $3.77 Million in Tenet Healthcare Corporation $THC

Livforsakringsbolaget Skandia Omsesidigt acquired a new position in Tenet Healthcare Corporation (NYSE:THC) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 18,600 shares of the company’s stock, valued at approximately $3,773,000.

Other hedge funds have also bought and sold shares of the company. Triumph Capital Management purchased a new stake in Tenet Healthcare in the third quarter worth about $25,000. William B. Walkup & Associates Inc. bought a new position in shares of Tenet Healthcare during the 3rd quarter valued at approximately $32,000. Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare in the 2nd quarter worth approximately $35,000. Westside Investment Management Inc. raised its stake in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares during the period. Finally, Trust Co. of Vermont bought a new position in shares of Tenet Healthcare in the third quarter worth approximately $41,000. Institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling

In related news, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the transaction, the executive vice president owned 8,012 shares in the company, valued at approximately $1,875,128.48. This trade represents a 74.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 46,517 shares of company stock worth $10,943,111. Corporate insiders own 0.81% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently commented on THC shares. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 1st. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. KeyCorp boosted their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, February 12th. Truist Financial increased their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Finally, Guggenheim boosted their price target on Tenet Healthcare from $271.00 to $283.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $250.56.

Tenet Healthcare Trading Down 3.4%

THC stock opened at $211.88 on Wednesday. The firm has a fifty day moving average price of $213.78 and a 200 day moving average price of $204.75. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $247.21. The firm has a market cap of $18.43 billion, a PE ratio of 13.68, a price-to-earnings-growth ratio of 1.06 and a beta of 1.39. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same quarter last year, the business earned $3.44 earnings per share. Tenet Healthcare’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.